Latest Applied genetics Stories
DALLAS, February 21, 2015 /PRNewswire/ -- RnRMarketResearch.com announces addition of Gene Therapy Hematological Disorders Insight and Gene Therapy Metabolic Disorders
23andMe's Personal Genome Service® 510(k) Submission for Bloom Syndrome Carrier Status Test Report Granted Marketing Authority through De Novo Classification MOUNTAIN VIEW, Calif.,
NEW YORK, Feb. 9, 2015 /PRNewswire/ -- A market for gene therapy exceeding $13 billion could be possible by 2025 if the technologies show success in the current trials underway.
Market Publishers Ltd announces that in-demand pipelines assessments prepared by DelveInsight have been recently added to its catalogue. London, UK (PRWEB) February
DALLAS, February 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Gene Therapy Respiratory Insight and Gene Therapy Immunology Insight market research reports on Pipeline
DUBLIN, January 27, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pfd99m/recombinant) has announced the addition of the "Recombinant
Agreement Provides Pfizer with Access to 23andMe's Research Portal; Companies to Establish New Lupus Research Community in 2015 MOUNTAIN VIEW, Calif., Jan.
Leading gene therapy Company will partner with established market leader to develop a potential new treatment paradigm for hemophilia B PHILADELPHIA, Dec.
For paternity and relationship DNA testing, Universal Forensics is introducing its new Elite 44 marker test designed to provide the highest degree of accuracy and reliability currently available.
- A political dynamiter.